Head-to-head
Oak Longevity vs Enhance MD
Compared on semaglutide across the eight dimensions this database records. They differ on 6 of those eight. Oak Longevity is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; Enhance MD is $212. Over twelve months that is $1,596 against $2,544. Value Scores are 95.6 and 58.1 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · Enhance MD plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and Enhance MD is $212 — $79 apart, or $948 across a year. Over twelve months the totals are $1,596 (billed monthly) and $2,544 (billed monthly).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Enhance MD charges a flat $212 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
| Dose | Oak Longevity | Rank | Enhance MD | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $212 | 20/32 | Oak Longevity by $79 |
| 0.5 mg | $133 | 3/21 | $212 | 14/21 | Oak Longevity by $79 |
| 1 mg | $133 | 3/21 | $212 | 14/21 | Oak Longevity by $79 |
| 1.7 mg | $133 | 3/21 | $212 | 14/21 | Oak Longevity by $79 |
| 2.4 mg | $133 | 3/29 | $212 | 16/29 | Oak Longevity by $79 |
Oak Longevity is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and Enhance MD sits 13. There are 10 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Oak Longevity is $4 above the cheapest semaglutide program on record. Enhance MD is $83 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, Enhance MD by $137. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | Enhance MD | Cheaper |
|---|---|---|---|
| Month to month | $133 | $212 | Oak Longevity by $79 |
| Settled dose | Oak Longevity | Enhance MD | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $2,544 | $948 apart |
| 0.5 mg | $1,596 | $2,544 | $948 apart |
| 1 mg | $1,596 | $2,544 | $948 apart |
| 1.7 mg | $1,596 | $2,544 | $948 apart |
| 2.4 mg | $1,596 | $2,544 | $948 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term; Enhance MD publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $2,544 on Enhance MD. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
Value Scores are 95.6 for Oak Longevity and 58.1 for Enhance MD, against a semaglutide category floor of $129. Oak Longevity leads by 37.5 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| Enhance MD | 42.6 | 10.5 | 0 | 5 | 58.1 |
Where the two programs differ
All-in monthly
Oak Longevity is cheaper month to month — $133 against $212, a gap of $79 every month, or $948 across a year if both rates hold.
Cancellation terms
Cancellation differs: Oak Longevity states Cancel before renewal, while Enhance MD states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Oak Longevity asks for Month-to-month; Enhance MD asks for Monthly, with a first-month discount on GLP-1 Core ($112 first month). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Oak Longevity charges one price at every dose; Enhance MD prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Oak Longevity's figure is provider-stated and Enhance MD's is reported. Oak Longevity rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $2,544 for Enhance MD. Oak Longevity is lower by $948 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
Enhance MD Official site
Enhance MD bundles GLP-1 medication inside a broader metabolic program including NAD+ coaching, lab testing every six months, and ongoing provider care. The price reflects the full metabolic bundle, not the GLP-1 alone; this makes Enhance MD's figures the least comparable in the database.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly, with a first-month discount on GLP-1 Core ($112 first month); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Enhance MD GLP-1 Core verified 2026-07-14
Watch: Figures reflect the bundled metabolic program price, not GLP-1 medication alone. Comparing Enhance MD's $212–$322 to medication-only programs overstates the GLP-1 cost while understating the breadth of service included. The $169 microdosing figure is the most medication-proximate but involves a different dosing protocol. Reported — RangeYourself 2026-07-14.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
Enhance MD carries tirzepatide at $280 a month and semaglutide at $212 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
Enhance MD does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Oak Longevity and Enhance MD for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Enhance MD carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Oak Longevity Official site wins this matchup. If you expect to titrate to the top of the ladder, oak longevity's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, oak longevity's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; Enhance MD's is reported as of 2026-07-14.
Questions
Is Oak Longevity or Enhance MD cheaper for semaglutide?
Oak Longevity is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $212, a difference of $79 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus Enhance MD?
Oak Longevity works out to $1,596 across twelve months and Enhance MD to $2,544, on the plan terms each publishes.
Does Oak Longevity or Enhance MD raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. Enhance MD: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and Enhance MD differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and Enhance MD names its pharmacy?
Neither. Oak Longevity records Partner 503A pharmacy (not publicly itemized) and Enhance MD records Partner 503A pharmacy (not named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Oak Longevity and Enhance MD prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. Enhance MD's is reported, captured 2026-07-14. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · Enhance MD official site. Compounded tirzepatide and semaglutide are not FDA-approved products.